Craig Dais - Jul 28, 2023 Form 3 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Chief Financial Officer
Signature
/s/ Gioia Gentile for Craig Dais, by power of attorney
Stock symbol
NAVB
Transactions as of
Jul 28, 2023
Transactions value $
$0
Form type
3
Date filed
8/15/2023, 06:53 PM
Next filing
Nov 14, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.